US Patent 7838699 Embolization using degradable crosslinked hydrogels
Patent 7838699 was granted and assigned to Biosphere Medical, Inc. on November, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7838699 Embolization using degradable crosslinked hydrogels
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.